Design
Review
No takes yet. Share an insight, caveat, or question.
NP genetic variants may guide future risk assessment in hypertension and MI; leaves open clinical translation of NP pathway modulation.
Tomohiro Nakayama (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: